How are technological advances impacting the selection of patients for clinical trials? What’s the impact of immunotherapy on cancer treatment? And how is response-to-therapy currently monitored?
Our current understanding of the basic biology of cancer disease is assisting physicians in stratifying patients for select therapies. Join us and learn more.
Event recording
Director of Clinical Research
Massachusetts General Hospital Cancer Center
Professor of Medicine
Harvard Medical School
Director and Professor
NCI-Designated Cancer Center
Sanford Burnham Prebys
Jeanne and Gary Herberger Leadership Chair in Cancer Research